Kura Oncology presented FIT-001 data on darlifarnib at the annual meeting of the American Society of Clinical Oncology.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kura Oncology presented FIT-001 data on darlifarnib at the annual meeting of the American Society of Clinical Oncology.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Kura Oncology
company in La Jolla, United States
Nothing else this week.
-
American Society of Clinical Oncology
organization
Nothing else this week.